Johnson & Johnson Vision to Launch Acuvue Oasys Max 1-Day Contact Lenses in Several Markets
Johnson & Johnson Vision announced it has received FDA clearance, Health Canada approval, and completed CE Mark activities for its latest contact lens, Acuvue Oasys Max 1-Day and Acuvue Oasys Max 1-Day Multifocal. The announcement comes during the 125th Annual AOA Congress and 54th Annual AOSA Conference: Optometry’s Meeting 2022 in Chicago (June 15-18).
The new contact lenses were developed to provide all day comfort and visual clarity,2,3 amidst feedback from eye care professionals and patients that today’s modern lifestyles, long hours, and increased use of digital devices are taking a toll on eye comfort, according to Johnson & Johnson Vision. A recent survey found the majority (71%) of eye care professionals are seeing patients who are experiencing eye discomfort related to increased screen-time,1 with young contact lens wearers spending an average of 9 hours per day in front of a screen,5,6,7 causing them to blink less and experience more dryness and eye fatigue.8,9,10
“Our lives have evolved significantly over the past few years creating increased demands on our eyes,” Peter Menziuso, Company Group Chairman, Johnson & Johnson Vision, said in a company news release. "As pioneers in eye health, we’re leading with high science and deep clinical expertise to innovate for those moments that matter. Acuvue Oasys Max 1-Day is the latest in our long heritage of leading-edge innovation and we look forward to bringing this solution for patients experiencing ever-demanding lifestyles and environments.”
Available in spherical and multifocal, Acuvue Oasys Max 1-Day contact lenses are designed to address multiple vision correction needs. They will be a premium range of daily disposable contact lenses designed for proven performance.2,3
The new lenses are anticipated to be made available in the US, Canada and multiple European countries in the fall.
Refernces
1 Jobson Optical Research, January 2021 n=503 ECPs.
2 JJV data on file, 2022. CSM Subjective Responses ACUVUE® OASYS MAX 1-Day Contact Lenses- Retrospective Meta-analysis
3 JJV Data on File 2022. Subjective Stand-Alone Claims for ACUVUE® OASYS MAX 1-Day MULTIFOCAL Contact Lenses - Exploratory Meta-analysis.
4 Forbes. Americans spent on average more than 1,300 hours on social media last year. https://www.forbes.com/sites/petersuciu/2021/06/24/americans-spent-more-than-1300-hours-on-social-media/?sh=5b6fd6c72547. Accessed May 2022.
5 Forbes. Online marketing as we know it is changing with the rise of Generation Z. https://www.forbes.com/sites/jiawertz/2018/09/30/online-marketing-as-we-know-it-is-changing-with-the-rise-of-generation-z/?sh=7ef7d28b65ab. Accessed May 2022.
6 U Swith. How much of your time is screen time? https://www.uswitch.com/mobiles/screentime-report/. Accessed May 2022
7 Tsubota K, Nakamori K. Dry eyes and video display terminals. N Engl J Med. 1993;328(8):584. doi: 10.1056/NEJM199302253280817.
8 Patel S, Henderson R, Bradley L. et al. Effect of visual display unit use on blink rate and tear stability. Optom vis Sci. 1991; 68(11):888-892. doi: 10.1097/00006324-199111000-00010.
9 JJV data on file, 2021. ACUVUE® OASYS Brand Family Digital Device Claims (ACUVUE® OASYS, ACUVUE® OASYS 1-DAY, and ACUVUE® OASYS with TRANSITIONS™.